Literature DB >> 26188212

Cholesterol efflux capacity in humans with psoriasis is inversely related to non-calcified burden of coronary atherosclerosis.

Taufiq Salahuddin1, Balaji Natarajan1, Martin P Playford1, Aditya A Joshi1, Heather Teague1, Youssef Masmoudi1, Mariana Selwaness2, Marcus Y Chen1, David A Bluemke2, Nehal N Mehta3.   

Abstract

AIMS: Cholesterol efflux capacity (CEC) was recently shown to predict future cardiovascular (CV) events. Psoriasis both increases CV risk and impairs CEC. However, whether having poor CEC is associated with coronary plaque burden is currently unknown. We aimed to assess the cross-sectional relationship between coronary plaque burden assessed by quantitative coronary computed tomography angiography (CCTA) with CEC in a well-phenotyped psoriasis cohort. METHODS AND
RESULTS: Total burden and non-calcified burden (NCB) plaque indices were assessed in 101 consecutive psoriasis patients using quantitative software. Cholesterol efflux capacity was quantified using a cell-based ex vivo assay measuring the ability of apoB-depleted plasma to mobilize cholesterol from lipid-loaded macrophages. Cholesterol efflux capacity was inversely correlated with NCB (unadjusted β-coefficient -0.33; P < 0.001), and this relationship persisted after adjustment for CV risk factors (β -0.24; P < 0.001), HDL-C levels (β -0.22; P < 0.001), and apoA1 levels (β -0.19; P < 0.001). Finally, we observed a significant gender interaction (P < 0.001) whereby women with low CEC had higher NCB compared to men with low CEC.
CONCLUSIONS: We show that CEC is inversely associated with prevalent coronary plaque burden measured by quantitative CCTA. Low CEC may therefore be an important biomarker for subclinical coronary atherosclerosis in psoriasis. CLINICALTRIALSGOV: NCT01778569. Published by Oxford University Press on behalf of the European Society of Cardiology 2015. This work is written by (a) US Government employee(s) and is in the public domain in the US.

Entities:  

Keywords:  Cholesterol efflux capacity (CEC); Coronary plaque burden; HDL efflux; Inflammatory atherogenesis; Lipids; Non-calcified plaque burden; Psoriasis; Quantitative coronary computed tomography angiography (CCTA)

Mesh:

Substances:

Year:  2015        PMID: 26188212      PMCID: PMC4604260          DOI: 10.1093/eurheartj/ehv339

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  15 in total

1.  Noninvasive assessment of plaque morphology and composition in culprit and stable lesions in acute coronary syndrome and stable lesions in stable angina by multidetector computed tomography.

Authors:  Udo Hoffmann; Fabian Moselewski; Koen Nieman; Ik-Kyung Jang; Maros Ferencik; Ayaz M Rahman; Ricardo C Cury; Suhny Abbara; Hamid Joneidi-Jafari; Stephan Achenbach; Thomas J Brady
Journal:  J Am Coll Cardiol       Date:  2006-03-27       Impact factor: 24.094

2.  HDL cholesterol efflux capacity and incident cardiovascular events.

Authors:  Anand Rohatgi; Amit Khera; Jarett D Berry; Edward G Givens; Colby R Ayers; Kyle E Wedin; Ian J Neeland; Ivan S Yuhanna; Daniel R Rader; James A de Lemos; Philip W Shaul
Journal:  N Engl J Med       Date:  2014-11-18       Impact factor: 91.245

3.  Effects of torcetrapib in patients at high risk for coronary events.

Authors:  Philip J Barter; Mark Caulfield; Mats Eriksson; Scott M Grundy; John J P Kastelein; Michel Komajda; Jose Lopez-Sendon; Lori Mosca; Jean-Claude Tardif; David D Waters; Charles L Shear; James H Revkin; Kevin A Buhr; Marian R Fisher; Alan R Tall; Bryan Brewer
Journal:  N Engl J Med       Date:  2007-11-05       Impact factor: 91.245

4.  Paradoxical association of enhanced cholesterol efflux with increased incident cardiovascular risks.

Authors:  Xin-Min Li; Wai Hong Wilson Tang; Marian K Mosior; Ying Huang; Yuping Wu; William Matter; Vivian Gao; David Schmitt; Joseph A Didonato; Edward A Fisher; Jonathan D Smith; Stanley L Hazen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-03-21       Impact factor: 8.311

5.  Effects of dalcetrapib in patients with a recent acute coronary syndrome.

Authors:  Gregory G Schwartz; Anders G Olsson; Markus Abt; Christie M Ballantyne; Philip J Barter; Jochen Brumm; Bernard R Chaitman; Ingar M Holme; David Kallend; Lawrence A Leiter; Eran Leitersdorf; John J V McMurray; Hardi Mundl; Stephen J Nicholls; Prediman K Shah; Jean-Claude Tardif; R Scott Wright
Journal:  N Engl J Med       Date:  2012-11-05       Impact factor: 91.245

Review 6.  Coronary CT angiography versus intravascular ultrasound for estimation of coronary stenosis and atherosclerotic plaque burden: a meta-analysis.

Authors:  Collin Fischer; Edward Hulten; Pallavi Belur; Ryan Smith; Szilard Voros; Todd C Villines
Journal:  J Cardiovasc Comput Tomogr       Date:  2013-08-23

7.  Abnormal lipoprotein particles and cholesterol efflux capacity in patients with psoriasis.

Authors:  Nehal N Mehta; Ron Li; Parasuram Krishnamoorthy; YiDing Yu; William Farver; Amrith Rodrigues; Anna Raper; Mackenzie Wilcox; Amanda Baer; Stephanie DerOhannesian; Megan Wolfe; Muredach P Reilly; Daniel J Rader; Abby VanVoorhees; Joel M Gelfand
Journal:  Atherosclerosis       Date:  2012-07-21       Impact factor: 5.162

8.  Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database.

Authors:  Nehal N Mehta; Rahat S Azfar; Daniel B Shin; Andrea L Neimann; Andrea B Troxel; Joel M Gelfand
Journal:  Eur Heart J       Date:  2009-12-27       Impact factor: 29.983

9.  Psoriatic arthritis and sacroiliitis are associated with increased vascular inflammation by 18-fluorodeoxyglucose positron emission tomography computed tomography: baseline report from the Psoriasis Atherosclerosis and Cardiometabolic Disease Initiative.

Authors:  Shawn Rose; Jenny Dave; Corina Millo; Haley B Naik; Evan L Siegel; Nehal N Mehta
Journal:  Arthritis Res Ther       Date:  2014-07-30       Impact factor: 5.156

10.  Anti-psoriatic therapy recovers high-density lipoprotein composition and function.

Authors:  Michael Holzer; Peter Wolf; Martin Inzinger; Markus Trieb; Sanja Curcic; Lisa Pasterk; Wolfgang Weger; Akos Heinemann; Gunther Marsche
Journal:  J Invest Dermatol       Date:  2013-08-28       Impact factor: 8.551

View more
  33 in total

1.  Pediatric Psoriasis Comorbidity Screening Guidelines.

Authors:  Emily Osier; Audrey S Wang; Megha M Tollefson; Kelly M Cordoro; Stephen R Daniels; Andrew Eichenfield; Joel M Gelfand; Alice B Gottlieb; Alexa B Kimball; Mark Lebwohl; Nehal N Mehta; Amy S Paller; Jeffrey B Schwimmer; Dennis M Styne; Abby S Van Voorhees; Wynnis L Tom; Lawrence F Eichenfield
Journal:  JAMA Dermatol       Date:  2017-07-01       Impact factor: 10.282

Review 2.  Lipid Abnormalities and Inflammation in HIV Inflection.

Authors:  Nicholas T Funderburg; Nehal N Mehta
Journal:  Curr HIV/AIDS Rep       Date:  2016-08       Impact factor: 5.071

3.  Coronary Plaque Characterization in Psoriasis Reveals High-Risk Features That Improve After Treatment in a Prospective Observational Study.

Authors:  Joseph B Lerman; Aditya A Joshi; Abhishek Chaturvedi; Tsion M Aberra; Amit K Dey; Justin A Rodante; Taufiq Salahuddin; Jonathan H Chung; Anshuma Rana; Heather L Teague; Jashin J Wu; Martin P Playford; Benjamin A Lockshin; Marcus Y Chen; Veit Sandfort; David A Bluemke; Nehal N Mehta
Journal:  Circulation       Date:  2017-05-08       Impact factor: 29.690

4.  Association Between Soluble Lectinlike Oxidized Low-Density Lipoprotein Receptor-1 and Coronary Artery Disease in Psoriasis.

Authors:  Amit K Dey; Ranjitha Gaddipati; Youssef A Elnabawi; Emily Ongstad; Aditya Goyal; Jonathan H Chung; Heather L Teague; Justin A Rodante; Aparna A Sajja; Alexander V Sorokin; Sundus S Lateef; Milena Aksentijevich; Harry Choi; Aarthi S Reddy; Nevin J Varghese; Jacob Groenendyk; Agastya D Belur; Leonard Genovese; Joshua P Rivers; Joseph Lerman; Mohammad Tarek Kabbany; Charlotte Harrington; Jenis Ortiz; Noor Khalil; Andrew Keel; Yvonne Baumer; Marcus Y Chen; David A Bluemke; Aditya A Joshi; Mariana J Kaplan; Alan T Remaley; Martin P Playford; Sotirios K Karathanasis; Joel M Gelfand; Ruchi Gupta; Nehal N Mehta
Journal:  JAMA Dermatol       Date:  2020-02-01       Impact factor: 10.282

Review 5.  HDL Cholesterol Efflux Capacity: Cardiovascular Risk Factor and Potential Therapeutic Target.

Authors:  Anish Bhatt; Anand Rohatgi
Journal:  Curr Atheroscler Rep       Date:  2016-01       Impact factor: 5.113

6.  Chronic skin inflammation accelerates macrophage cholesterol crystal formation and atherosclerosis.

Authors:  Yvonne Baumer; Qimin Ng; Gregory E Sanda; Amit K Dey; Heather L Teague; Alexander V Sorokin; Pradeep K Dagur; Joanna I Silverman; Charlotte L Harrington; Justin A Rodante; Shawn M Rose; Nevin J Varghese; Agastya D Belur; Aditya Goyal; Joel M Gelfand; Danielle A Springer; Christopher Ke Bleck; Crystal L Thomas; Zu-Xi Yu; Mårten Cg Winge; Howard S Kruth; M Peter Marinkovich; Aditya A Joshi; Martin P Playford; Nehal N Mehta
Journal:  JCI Insight       Date:  2018-01-11

7.  Serum active 1,25(OH)2D, but not inactive 25(OH)D vitamin D levels are associated with cardiometabolic and cardiovascular disease risk in psoriasis.

Authors:  Martin P Playford; Amit K Dey; Claudia Zierold; Aditya A Joshi; Frank Blocki; Fabrizio Bonelli; Justin A Rodante; Charlotte L Harrington; Joshua P Rivers; Youssef A Elnabawi; Marcus Y Chen; Mark A Ahlman; Heather L Teague; Nehal N Mehta
Journal:  Atherosclerosis       Date:  2019-08-17       Impact factor: 5.162

8.  Neutrophil subsets and their gene signature associate with vascular inflammation and coronary atherosclerosis in lupus.

Authors:  Philip M Carlucci; Monica M Purmalek; Amit K Dey; Yenealem Temesgen-Oyelakin; Simantini Sakhardande; Aditya A Joshi; Joseph B Lerman; Alice Fike; Michael Davis; Jonathan H Chung; Martin P Playford; Mohammad Naqi; Pragnesh Mistry; Gustavo Gutierrez-Cruz; Stefania Dell'Orso; Faiza Naz; Taufiq Salahuddin; Balaji Natarajan; Zerai Manna; Wanxia L Tsai; Sarthak Gupta; Peter Grayson; Heather Teague; Marcus Y Chen; Hong-Wei Sun; Sarfaraz Hasni; Nehal N Mehta; Mariana J Kaplan
Journal:  JCI Insight       Date:  2018-04-19

9.  Cholesterol efflux capacity of high-density lipoprotein correlates with survival and allograft vasculopathy in cardiac transplant recipients.

Authors:  Ali Javaheri; Maria Molina; Payman Zamani; Amrith Rodrigues; Eric Novak; Susan Chambers; Patricia Stutman; Wilhelmina Maslanek; Mary Williams; Scott M Lilly; Peter Heeger; Mohamed H Sayegh; Anil Chandraker; David M Briscoe; Kevin P Daly; Randall Starling; David Ikle; Jason Christie; J Eduardo Rame; Lee R Goldberg; Jeffrey Billheimer; Daniel J Rader
Journal:  J Heart Lung Transplant       Date:  2016-07-15       Impact factor: 10.247

10.  Visceral Adiposity in Psoriasis is Associated With Vascular Inflammation by 18F-Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography Beyond Cardiometabolic Disease Risk Factors in an Observational Cohort Study.

Authors:  Joshua P Rivers; Tiffany M Powell-Wiley; Amit K Dey; Justin A Rodante; Jonathan H Chung; Aditya A Joshi; Balaji Natarajan; Aparna P Sajja; Abhishek Chaturvedi; Anshuma Rana; Charlotte L Harrington; Heather L Teague; Benjamin N Lockshin; Mark A Ahlman; Jianhua Yao; Martin P Playford; Joel M Gelfand; Nehal N Mehta
Journal:  JACC Cardiovasc Imaging       Date:  2017-10-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.